BioHiTech Global Inc. [NASDAQ: BHTG] traded at a high on 01/21/21, posting a 25.00 gain after which it closed the day’ session at $1.75. The company report on December 16, 2020 that BioHiTech Receives New Food Waste Digester Orders from Holland America and P&O Cruises and Additional Orders from Princess Cruises.
BioHiTech Global, Inc. (“BioHiTech” or the “Company”) (NASDAQ: BHTG), a sustainable technology and services company, announced it has received a new purchase order for its Revolution Series™ food digesters from Holland America Line valued at approximately $700,000 and an additional order from Princess Cruises valued at approximately $650,000, which will include three new ships from that line. In addition, the company received an order valued at $90,000 from Australia-based P&O Cruises – the first order for this brand, which is also under the Carnival umbrella. BioHiTech expects to fulfil the orders through the first quarter of 2021.
“This is an important milestone for BioHiTech demonstrating our growing relationship with Carnival Corp.’s third and fourth brands, Holland America Line and P&O Cruises, while adding to our service of Carnival’s Princess Cruises as well,” commented Tony Fuller, BioHiTech’s Chief Executive Officer. “As Carnival Cruise Lines, Holland America, Princess, P&O Cruises, and the rest of the Carnival family of brands move toward a resumption of the cruise business, we are pleased to be part of their sustainable food waste management systems and enhanced stewardship over the environment.”.
The results of the trading session contributed to over 3540062 shares changing hands. Over the past one week, the price volatility of BioHiTech Global Inc. stands at 10.88% while the volatility over the past one month is 7.90%.
The market cap for BHTG stock reached $42.05 million, with 22.05 million shares outstanding and 18.17 million shares in the current float. Compared to the average trading volume of 569.61K shares, BHTG reached a trading volume of 3540062 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about BioHiTech Global Inc. [BHTG]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for BHTG shares is $2.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on BHTG stock is a recommendation set at 2.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Average True Range (ATR) for BioHiTech Global Inc. is set at 0.12, with the Price to Sales ratio for BHTG stock in the period of the last 12 months amounting to 9.56.
How has BHTG stock performed recently?
BioHiTech Global Inc. [BHTG] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 7.03. With this latest performance, BHTG shares gained by 44.63% in over the last four-week period, additionally sinking by -21.88% over the last 6 months – not to mention a drop of -11.17% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for BHTG stock in for the last two-week period is set at 71.16, with the RSI for the last a single of trading hit 74.90, and the three-weeks RSI is set at 67.73 for BioHiTech Global Inc. [BHTG]. The present Moving Average for the last 50 days of trading for this stock 1.2984, while it was recorded at 1.5000 for the last single week of trading, and 1.3997 for the last 200 days.
BioHiTech Global Inc. [BHTG]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and BioHiTech Global Inc. [BHTG] shares currently have an operating margin of -170.37 and a Gross Margin at -11.17. BioHiTech Global Inc.’s Net Margin is presently recorded at -180.66.
Return on Total Capital for BHTG is now -15.05, given the latest momentum, and Return on Invested Capital for the company is -19.35. Return on Equity for this stock declined to -218.65, with Return on Assets sitting at -13.63. When it comes to the capital structure of this company, BioHiTech Global Inc. [BHTG] has a Total Debt to Total Equity ratio set at 1,424.44. Additionally, BHTG Total Debt to Total Capital is recorded at 93.44, with Total Debt to Total Assets ending up at 69.30.
Reflecting on the efficiency of the workforce at the company, BioHiTech Global Inc. [BHTG] managed to generate an average of -$195,460 per employee. Receivables Turnover for the company is 3.30 with a Total Asset Turnover recorded at a value of 0.08.BioHiTech Global Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.50 and a Current Ratio set at 0.50.
Earnings analysis for BioHiTech Global Inc. [BHTG]
With the latest financial reports released by the company, BioHiTech Global Inc. posted -0.15/share EPS, while the average EPS was predicted by analysts to be reported at -0.15/share. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for BHTG.
Insider trade positions for BioHiTech Global Inc. [BHTG]
There are presently around $1 million, or 1.80% of BHTG stock, in the hands of institutional investors. The top three institutional holders of BHTG stocks are: RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC. with ownership of 118,685, which is approximately 0% of the company’s market cap and around 6.30% of the total institutional ownership; VANGUARD GROUP INC, holding 87,718 shares of the stock with an approximate value of $0.12 million in BHTG stocks shares; and STEWARD PARTNERS INVESTMENT ADVISORY, LLC, currently with $78000.0 in BHTG stock with ownership of nearly 0% of the company’s market capitalization.
Positions in BioHiTech Global Inc. stocks held by institutional investors increased at the end of April and at the time of the April reporting period, where 7 institutional holders increased their position in BioHiTech Global Inc. [NASDAQ:BHTG] by around 86,725 shares. Additionally, 6 investors decreased positions by around 43,757 shares, while 9 investors held positions by with 291,545 shares. The mentioned changes placed institutional holdings at 422,027 shares, according to the latest SEC report filing. BHTG stock had 5 new institutional investments in for a total of 69,876 shares, while 5 institutional investors sold positions of 36,719 shares during the same period.